Connection
Bradley Martin to Warfarin
This is a "connection" page, showing publications Bradley Martin has written about Warfarin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.988 |
|
|
|
-
Shah A, Shewale A, Hayes CJ, Martin BC. Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients. Stroke. 2016 06; 47(6):1555-61.
Score: 0.475
-
Casciano JP, Singer DE, Kwong WJ, Fox ES, Martin BC. Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use. Am J Cardiovasc Drugs. 2012 Oct 01; 12(5):313-23.
Score: 0.371
-
Casciano JP, Dotiwala ZJ, Martin BC, Kwong WJ. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective. J Manag Care Pharm. 2013 May; 19(4):302-16.
Score: 0.097
-
Nerurkar J, Wade WE, Martin BC. Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty. Pharmacotherapy. 2002 Aug; 22(8):990-1000.
Score: 0.046